Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are efficacious glucose-lowering medications with salient benefits for body weight and cardiovascular events. This class of medications is now recommended as the top priority for patients with established cardiovascular disease or indicators of high...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academya Publishing Co.
2021-02-01
|
| Series: | Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | http://www.e-enm.org/upload/pdf/enm-2021-102.pdf |